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This is the ﬁrst report concerning the a-glucosidase, a-amylase and protein tyrosine phosphatase 1B
(PTP1B) inhibitory activities of cinnamon twig extracts. Comparing the antihyperglycemic activity of
renewable plant parts, indigenous cinnamon (Cinnamomum osmophloeum; 土肉桂 tǔ rou guì) twig ex-
tracts (CoTE) showed better a-glucosidase and a-amylase activities than leaf, 2-cm branch and 5-cm
branch extracts. Chemotype of C. osmophloeum has no inﬂuence on the antihyperglycemic activities
and proanthocyanidin contents of CoTE. Among four soluble fractions obtained from CoTE by following
bioactivity-guided fractionation procedure, the n-butanol soluble fraction (BSF) with abundant proan-
thocyanidins and condensed tannins, exhibited the best antihyperglycemic and PTP1B inhibitory activ-
ities. In addition, the BSF displayed the excellent DPPH free-radical scavenging and ferrous ion-chelating
activities. The antihyperglycemic and antioxidant activities of all four soluble fractions from CoTE showed
high correlation coefﬁcient with their proanthocyanidin and condensed tannin contents. Furthermore,
CoTE had no toxicity on 3T3-L1 preadiocytes. Results obtained demonstrated that CoTE has excellent
antihyperglycemic, antioxidant and PTP1B inhibitory activities, and thus has great potential as a source
for natural health products.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The incidence and prevalence of type 2 diabetes have acutely
increased since 1990. A dramatic 64% growth between 2010 and
2025 is predicted, inﬂuencing 53.1 million people and posing an
extremely huge medical and societal cost. The incidence of type 2
diabetes is highly related to age, inheritance, diet, lifestyle and
environmental pressure.1 Obesity showed high correlation with
risk of type 2 diabetes, and aggravated insulin resistance of type 2
diabetes. Excessive nutrients lead to energy overload, thus affecting
themetabolic function of adipocytes. The dysfunction of adipocytes
would cause generation of reactive oxygen species (ROS), change
secretion of adipokines, increase release of fatty acids and inﬂam-
matory factors. Overload of free fatty acids would result inource Conservation, National
aipei 10617, Taiwan.
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).lipotoxicity and dyslipidemia, which in turn affect uptake of
glucose and insulin sensitivity.2,3
Besides injection of insulin, there are three kinds of hypogly-
cemic drugs, namely insulin secretagogues, insulin sensitizers and
a-glucosidase inhibitors for maintaining glucose homeostasis in
type 2 diabetes patients.4 These commercial hypoglycemic drugs
also have many side effects.5 The antihyperglycemic assays, such as
a-glucosidase inhibition, a-amylase inhibition, protein tyrosine
phosphatase 1B (PTP1B) inhibition and glucose uptake in cells are
commonly used to estimate the beneﬁcial effects on the treatment
of type 2 diabetes. Over 400 plant extracts have been estimated for
the treatment of diabetes throughout the world. Several phyto-
chemicals in plant extracts were evaluated by antihyperglycemic
assays andmight havemultiple beneﬁts on type 2 diabetes to avoid
side effects.6 Aqueous extract from Cinnamomum burmannii bark is
rich in proanthocyanidins.7 It was also reported that extracts of
C. burmannii contained proanthocyanidins with A-type linkage and
had insulin-like biological activity.8 Furthermore, four water ex-
tracts of Cinnamomun bark were reported to have signiﬁcant
inhibitory activities of glucose metabolic enzymes, and might bersity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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drugs.9
Studies have showed that the coumarin contents in commercial
cinnamons, such as Cinnamomum cassia and C. burmannii, are high.
The average coumarin content in C. cassia barks and twigs was
5790 mg/kg of sample, and coumarin contents in C. burmannii bark
were between 2140 and 9300 mg/kg of sample.10,11 Coumarin was
reported that have hepatotoxic and carcinogenic effects in ani-
mals.12,13 The results of no observed-adverse-effect level for liver
toxicity in the most sensitive animal species led the European Food
Safety Authority to establish a tolerable daily intake of 0.1 mg of
coumarin/kg body weight.
Cinnamomum osmophloeum (Lauraceae) (土肉桂 tǔ rou guì) is an
endemic species in Taiwan and its leaves have high cinnamalde-
hyde and low coumarin contents.14 Meanwhile, coumarin was not
detected in the essential oil of C. osmophloeum twig.15 However,
studies on the antihyperglycemic activities of C. osmophloeum twig
are lacking, hence its inhibitory activities of glucose metabolic en-
zymes and active components merit investigation.
With the consideration for sustainability and non-destructive
utilization, twigs and branches of C. osmophloeum were used in
this study instead of the bark. The antihyperglycemic activities
were evaluated by a-glucosidase and a-amylase inhibitory assay.
Inhibition of these two glucose metabolic enzymes could decrease
the absorption rate of glucose to prevent acute rise of postprandial
blood glucose of type 2 diabetes.16 PTP1B inhibitory activities of
cinnamon twigs have not been investigated yet. PTP1B has been
known to play an important role in inhibiting signaling pathways of
insulin and leptin receptors. PTP1B-knockout animals need lower
insulin to activate glucose uptake of cells and decreased weight.17
Therefore, beneﬁt effect on insulin and leptin sensitivities were
evaluated by PTP1B inhibitory assay. DPPH free-radical scavenging
and ferrous ion-chelating activity were utilized to estimate the
antioxidant activities. The active components were presumed by
the correlation analysis between different phenolic contents and
bioactivities. Finally, the viability of 3T3-L1 preadipocytes was
examined for the toxicity of extracts. With the above-mentioned
assays, the antihyperglycemic potency of C. osmophloeum twigs
for nature health products could be elucidated.
2. Materials and methods
2.1. Chemicals
Analytical grade solvents for extraction and chromatography
were purchased from Echo Chemical Co. (Taiwan). a-Glucosidase
from Bacillus stearothermophilus, a-amylase from porcine pancreas,
3,5-dinitrosalicylic acid (DNS), 4-nitrophenyl phosphate disodium
salt hexahydrate (pNPP), 1,1-diphenyl-2-picrylhydrazyl (DPPH) free
radical, 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-40,400-disulfonic
acid sodium salt (Ferrozine), trizma hydrochloride (TriseHCl), DL-
dithiothreitol (DTT), (þ)-catechin hydrate, acarbose and rutin hy-
drate were purchased from Sigma Chemical Co. (USA). p-Nitro-
phenyl-a-D-glucopyranoside (pNPG), KNaC4H4O6$4H2O, quercetin
dihydrate, ethylenediaminetetraacetic acid disodium salt (EDTA-
Na2), FeCl2$4H2O, NH4Fe(SO4)2$12H2O and thiazolyl blue tetrazo-
lium bromide (MTT) were purchased from Acros (Belgium). Ursolic
acid, citric acid, vanillin and AlCl3$6H2O were purchased from
Merck (Germany). PTP1B from human was purchased from Enzo
Life Sciences (Switzerland). Dulbecco's modiﬁed Eagle's medium
(DMEM) and newborn calf serum (NCS)were purchased fromGibco
BRL (USA). Melacacidin was separated and puriﬁed from Acacia
confusa root according to Lin and Chang.18 All other unlabelled
chemicals and reagents were purchased from Sigma Chemical Co.
(USA).2.2. Sampling of plant materials
The leaf, twig (diameter < 0.5 cm), 2-cm and 5-cm branch of
cinnamaldehyde type and the other two chemotypes of twig,
including mixed and linalool types of C. osmophloeum (土肉桂 tǔ
rou guì) were collected in the July of 2012 from the Hsin-Sheng
Nursery (24.841532N, 121.533524E) in New Taipei city, and the
trees were about 30 years. The species was identiﬁed by Mr. Yen-
Ray Hsui (Taiwan Forestry Research Institute) and the materials
were deposited at the laboratory of Wood chemistry (School of
Forestry and Resource Conservation, National Taiwan University).2.3. Extraction and isolation
Those dried samples were grounded into powder and soaked in
70% acetone at ambient temperature for seven days. The anti-
hyperglycemic twig crude extracts were then extracted succes-
sively with n-hexane, ethyl acetate, n-butanol, and water to yield
the n-hexane soluble fraction (HSF, 4.0%), ethyl acetate soluble
fraction (EASF, 4.7%), n-butanol soluble fraction (BSF, 55.4%), and
water soluble fraction (WSF, 35.9%). Each fractionwas tested by the
various assays including a-glucosidase inhibition, a-amylase inhi-
bition, PTP1B inhibition, DPPH free-radical scavenging activity, and
ferrous ion-chelating activity to determine the best active fraction.2.4. Inhibitory assay for a-glucosidase
The inhibitory activity of a-glucosidase was estimated according
to Lin and Lee.19 Brieﬂy, 20 mL of ddH2O, 10 mL of extracts/50%
methanol with different concentrations (1e100 mg/mL) and 60 mL of
0.25 unit/mL a-glucosidase/0.1 M phosphate buffer (pH 7.0) were
mixed together. The mixture was incubated at 37 C for 10 min, and
then the reaction was initiated by the addition of 10 mL of 20 mM
pNPG/0.1 M phosphate buffer for 10 min incubation and the
absorbance was measured at 405 nm. Acarbose was used as a
positive control.2.5. Inhibitory assay for a-amylase
The inhibitory activity of a-amylase was estimated according to
Apostolidis et al20 with slight modiﬁcations. Brieﬂy, 50 mL of ex-
tracts/50% methanol with different concentrations (25e1000 mg/
mL) were mixed with 50 mL of 0.5 mg/mL a-amylase/20 mM
phosphate buffer (pH 6.9). The mixture was incubated at 37 C for
10min, and then added 50 mL of 1% starch/20mMphosphate buffer.
After 10 min of incubation at 37 C, added 100 mL of reagent (1%
DNS in 0.4 M NaOH/ddH2O of 12% KNaC4H4O6$4H2O/ddH2O) and
incubated at 100 C for 15min. Finally, total volumewasmade up to
1.25 mL with ddH2O and the absorbance was measured at 405 nm.
Acarbose was used as a positive control.2.6. Inhibitory assay for PTP1B
Method of this assay was carried out according to Na et al21 with
slight modiﬁcation. Brieﬂy, 10 mL of extract/10% DMSO with
different concentrations (0.1e100 mg/mL), 10 mL of 2 mM pNPP/
50mM citrate buffer (pH 6.0, 0.1MNaCl,1mMEDTA-Na2 and 1mM
DTT) and 100 mL of 1 mg/mL PTP1B/50mM citrate buffer weremixed
together. The mixture was incubated at 37 C for 30 min, and then
added 100 mL of 1 N NaOH/ddH2O to stop the reaction. The absor-
bance was measured at 405 nm. Ursolic acid was used as a positive
control.
G.-M. Lin et al. / Journal of Traditional and Complementary Medicine 6 (2016) 281e288 2832.7. DPPH free-radical scavenging activity assay
The DPPH free-radical scavenging activity was examined ac-
cording to Chang et al.22 Brieﬂy,10 mL of the extracts/methanol with
different concentrations (1e100 mg/mL), 200 mL of 0.1 mM DPPH/
ethanol and 90 mL of 50 mM TriseHCl buffer (pH 7.4) were mixed
together. The mixture stood was incubated at ambient temperature
in dark for 30 min. The reduction of DPPH free-radical was
measured at 517 nm. Quercetin was used as a positive control.
2.8. Ferrous ion-chelating activity assay
The chelating effect of ferrous ions was evaluated according to
Dinis et al23 with slight modiﬁcations. Brieﬂy, 100 mL of the extracts
solution/DMSO, 370 mL of 50mM TriseHCl buffer (pH 7.4) and 10 mL
of 2 mM FeCl2/ddH2O were mixed together. The reaction was
initiated by adding 20 mL of 5 mM ferrozine/ddH2O with vigorous
shake, and incubated at ambient temperature for 10 min, and the
absorbance was measured at 562 nm. EDTA-Na2 was used as a
positive control.
2.9. Determination of proanthocyanidin contents
Amodiﬁed vanillin-H2SO4 assay of Hsieh et al24 was adopted for
examination of the proanthocyanidin contents. Brieﬂy, 50 mL of
extracts/methanol, 125 mL of 1% vanillin/methanol, and 125 mL of
10% H2SO4/methanol were mixed together. After the mixture was
incubated at 30 C for 15 min, the absorbance was measured at
500 nm. The calibration curve was performed with (þ)-catechin
and expressed as (þ)-catechin equivalent (CE) in milligrams per
gram sample.
2.10. Determination of condensed tannins contents
A modiﬁed acid-butanol assay of Hagerman25 was adopted for
examination of the condensed tannins. Brieﬂy, 450 mL of 5% HCl/n-
butanol, 75 mL of extracts/DMSO and 15 mL of 2% NH4Fe(SO4)2/
ddH2O were mixed together. After the mixture was incubated at
100 C for 50 min, the absorbance was measured at 550 nm. The
calibration curve was performed with melacacidin and expressed
as melacacidin equivalent (ME) in milligrams per gram sample.
2.11. Determination of ﬂavonoid contents
The AlCl3 method of Quettier-Deleu et al26 was used for deter-
mination of the total ﬂavonoid contents. 150 mL of extracts/meth-
anol and 150 mL of 2% AlCl3/methanol were mixed together. After
the mixture was incubated at ambient temperature for 10 min, the
absorbance of reaction mixture was read at 450 nm for quercetin
and 435 nm for rutin. The calibration curve was performed withTable 1
a-Glucosidase, a-amylase inhibitory activities and proanthocyanidin contents of 70 % ace
Specimen Chemotypes IC50 (mg/mL
a-Glucosida
Leaf Cinnamaldehyde 23.2 ± 0.1a
2-cm Br Cinnamaldehyde 6.7 ± 0.0b
5-cm Br Cinnamaldehyde 6.3 ± 0.1b
Twig Cinnamaldehyde 3.8 ± 0.2c
Twig Linalool 3.6 ± 0.0c
Twig Mixed 3.5 ± 0.1c
Mean ± SE (n ¼ 3). Different letters (aec) in the table are signiﬁcantly different at the leve
Br ¼ branch. TPAC ¼ total proanthocyanidin contents, CE ¼ (þ)-Catechin equivalent. IC
12.5 mg/mL, respectively.quercetin and rutin. The results were expressed as quercetin
equivalents (QE) and rutin equivalents (RE) in milligrams per gram
sample.
2.12. Cell culture
The 3T3-L1 preadipocytes were purchased from Bioresource
Collection and Research Center (BCRC). Cells were cultured in 10-
cm plastic dishes with DMEM, containing 10% NCS. Cells were
incubated at 37 C in a humidiﬁed atmosphere of 5% CO2.
2.13. Cell viability assay
Method of this assay was carried out according to Kim et al27
with slight modiﬁcations. 3T3-L1 preadipocytes were seeded in
96-well microtiter plates at a density of 2  105 cells/100 mL/well
and grown for 4 h for adherence. The cells were treated with test
samples in fresh DMEM at different concentrations. After 24 h in-
cubation at 37 C in a 5% CO2 incubator, 0.5 mg/mLMTT/DMEMwas
added and incubated for 1 h. The supernatant was removed after
culture, and the insoluble formazan product was dissolved in
100 mL of DMSO. The absorbance of formazan was measured at
570 nm.
2.14. Statistical analysis
All results are expressed as means ± standard error (SE) (n ¼ 3).
The signiﬁcance of difference was calculated by Scheffe's test, and
results with p < 0.05 were considered to be signiﬁcant. The corre-
lation was calculated by Pearson's test, and results with p < 0.05
were considered to be signiﬁcant.
3. Results and discussion
3.1. Antihyperglycemic activities and proanthocyanidin contents of
extracts from different plant parts of C. osmophloeum (土肉桂 tǔ rou
guì)
The a-glucosidase and a-amylase inhibitory activities of 70%
acetone extracts from different parts (twig, 2-cm branch, 5-cm
branch, and leaf) of C. osmophloeum were determined and acar-
bose, a clinical drug, was used as a positive control. As shown in
Table 1, the IC50 values of a-glucosidase inhibitory activity in
increasing order are as follows: twigs (3.8 mg/mL) < 5-cm branch
(6.3 mg/mL)  2-cm branch (6.7 mg/mL) < leaf (23.2 mg/mL).
Moreover, of the four different plant parts studied, the a-amylase
and a-glucosidase inhibitory activities showed similar trends, with
twigs exhibiting the best a-amylase inhibitory activity
(IC50 ¼ 84.5 mg/mL). On the other hand, the proanthocyanidin
contents in decreasing order are as follows: 5-cm branch (495.1 mgtone extracts from different chemotypes and plant parts of C. osmophloeum.
) TPAC
se a-Amylase CE/extract (mg/g)
> 1000 e
250.1 ± 4.6a 495.1 ± 4.8a
232.5 ± 4.2a 449.5 ± 5.5a
84.5 ± 10.0b 363.8 ± 3.0b
90.3 ± 1.3b 370.7 ± 3.7b
105.6 ± 4.2b 346.5 ± 3.9b
l of p < 0.05 according to Scheffe's test. e ¼ not detected. Twig ¼ diameter < 0.5 cm,
50 values of acarbose against a-glucosidase and a-amylase were 0.004 mg/mL and
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g) > leaf (trace). These results indicated that leaf extract contained
no proanthocyanidins and had weak antihyperglycemic activities.
Even with lower proanthocyanidins, twigs showed better anti-
hyperglycemic activity than branches. Therefore, it is rationally
presumed that twigs may have other different active components.
Salehi et al28 reported that the methanolic extracts of Cinna-
momum zeylanicum bark had an excellent a-amylase inhibitory
activity (IC50 value was about 38 mg/mL) in the ten plant extracts
traditionally used in Iran for diabetes. In another study, Lin and
Lee19 reported that aesculitannin B had better a-glucosidase
inhibitory activity (IC50 ¼ 3.0 mg/mL) than other compounds from
Machilus philippinensis leaf. Compared with the above-mentioned
results, the C. osmophloeum twig extracts (CoTE) in this study
showed a similar a-amylase inhibitory activity as that of the
methanolic extracts of C. zeylanicum bark and a similar a-glucosi-
dase inhibitory activity as that of aesculitannin B. Shihabudeen
et al29 reported that the methanolic extracts of C. zeylanicum bark
exhibited a strong in vitro a-glucosidase inhibitory activity and
inhibited effectively the maltase and sucrase for suppression of
postprandial blood glucose spikes in rats. Hence, it is of note that
CoTE has excellent a-glucosidase inhibitory activity and the po-
tency of in vivo antihyperglycemic activity.3.2. Antihyperglycemic activity and proanthocyanidin contents of
extracts from different chemotypes of C. osmophloeum twigs
The leaf essential oils of C. osmophloeum could be classiﬁed into
six chemotypes by GC/MS and cluster analyses.30 Cinnamaldehyde
type, linalool type and mixed type were selected and tested using
antihyperglycemic assays in order to understand whether chemo-
types inﬂuence the antihyperglycemic activities of CoTE.
As seen in Table 1, no signiﬁcant difference in antihyperglycemic
activity and proanthocyanidin contents between CoTE of different
chemotypes, indicating that chemotypes have no inﬂuence on the
antihyperglycemic activities and proanthocyanidin contents of
CoTE.
Similar to C. cassia bark oil, essential oils from cinnamaldehyde
type of C. osmophloeum leaf comprisedmainly cinnamaldehyde and
rarely coumarin.14,30 Babu et al31 reported that cinnamaldehyde
had antihyperglycemic and antihyperlipidemic activities in
streptozotocin-induced diabetic rats. The hot water extracts from
C. osmophloeum leaves could enhance secretion of adiponectin,
activation of glucose transporter type 4 (GLUT4) translocation and
phosphorylation of insulin receptor-b in 3T3-L1 adipocytes.32
Moreover, these hot water extracts also had antihyperlipidemic
activities and increased high-density lipoprotein in golden Syrian
hamsters fed with high-cholesterol diet.33
According to above-mentioned studies, it is obvious that the
essential oils from cinnamaldehyde type of C. osmophloeum leaf
have both antihyperglycemic and antihyperlipidemic activities.Table 2
Proanthocyanidin, condensed tannin and ﬂavonoid contents of CoTE and its soluble frac
Specimen TFC
QE/extract (mg/g) RE/extract (mg/
Crude 1.4 ± 0.0c 10.7 ± 0.1c
HSF 0.0 ± 0.1d 0.5 ± 0.2d
EASF 6.0 ± 0.1a 52.7 ± 1.0a
BSF 4.1 ± 0.1b 21.6 ± 0.4b
WSF 0.0 ± 0.0d 0.7 ± 0.1d
Mean ± SE (n¼ 3). Different letters (aee) in the table are signiﬁcantly different at the leve
acetate soluble fraction, BSF ¼ n-butanol soluble fraction, WSF ¼ water soluble fra
CTC ¼ condensed tannin contents, CE ¼ (þ)-catechin equivalent, ME ¼ melacacidin equFurthermore, the hot water extracts from cinnamaldehyde type of
C. osmophloeum leaf exhibited similar activities. Twig is a young-
woody part and connects to leaf. Rough harvest of leaves from
cinnamaldehyde type of C. osmophloeum trees accompanied some
twigs. In this study, CoTE exhibited better antihyperglycemic ac-
tivities than leaf extracts. It is worthy to investigate active com-
ponents in the CoTE. To explore the further utilization of
C. osmophloeum renewable plant parts, twigs of cinnamaldehyde-
type C. osmophloeum were chosen for the subsequent tests.
3.3. Various phenolic contents of soluble fractions from CoTE
According to the aforesaid results, CoTE had the best anti-
hyperglycemic activities. To determine the structure of active
compounds in the extracts, an in vitro bioactivity-guided fraction-
ation procedure was carried out. The fractionation was done by
successive liquid-liquid partition with n-hexane, ethyl acetate, n-
butanol, and water to yield four soluble fractions. Then, proan-
thocyanidin, condensed tannin and ﬂavonoid contents in the crude
extract and its four soluble fractions were quantitated.
As shown in Table 2, the proanthocyanidin contents in
decreasing order are as follows: BSF (561.1 mg of CE/g) > crude
(402.6 mg of CE/g) >WSF (189.0 mg of CE/g) > EASF (88.4 mg of CE/
g) > HSF (1.5 mg of CE/g). Moreover, condensed tannin of crude
extract and its four soluble fractions showed a similar trend as that
of proanthocyanidin contents, with BSF having the highest
condensed tannin content (331.5 mg ME/g). In the crude extract
and its four soluble fractions, the ﬂavonoid contents calculated by
quercetin equivalent were lower than 10 mg of QE/g. However, the
ﬂavonoid contents expressed as rutin equivalent in decreasing or-
der are as follows: EASF (52.7 mg of ME/g) > BSF (21.6 mg of ME/
g) > crude (10.7 mg of ME/g) >WSF (0.7 mg of ME/g) > HSF (0.5 mg
of ME/g). These results indicated that crude extracts of
C. osmophloeum had abundant proanthocyanidins and condensed
tannins in BSF, while EASF had the highest contents of ﬂavonoid
glycosides.
3.4. Antihyperglycemic and PTP1B inhibitory activity of soluble
fractions from CoTE
PTP1B plays an important role as a regulator of insulin and
leptin signal pathway, and many studies have explored its potential
as a validated therapeutic target for the treatment of type 2 dia-
betes and obesity.22 In this study, not only a-glucosidase and a-
amylase assayswere employed to determine the antihyperglycemic
activity, PTP1B assay was also utilized to determine the improve-
ment of insulin or leptin resistance in the crude extract and its four
soluble fractions.
As shown in Fig. 1A, the IC50 values of a-glucosidase inhibitory
activity in increasing order are as follows: BSF (3.6 mg/mL)  crude
(3.8 mg/mL) < EASF (7.0 mg/mL) <WSF (7.7 mg/mL) < HSF (16.9 mg/tions.
TPAC CTC
g) CE/extract (mg/g) ME/extract (mg/g)
402.6 ± 2.9b 258.2 ± 5.7b
1.5 ± 0.3e 22.7 ± 0.3e
88.4 ± 1.0d 90.6 ± 0.7d
561.1 ± 2.4a 331.5 ± 3.8a
189.0 ± 1.9c 125.5 ± 3.2c
l of p < 0.05 according to Scheffe's test. HSF¼ n-hexane soluble fraction, EASF¼ ethyl
ction. TFC ¼ total ﬂavonoid contents, TPAC ¼ total proanthocyanidin contents,
ivalent, QE ¼ quercetin equivalent, RE ¼ rutin equivalent.
Fig. 1. IC50 values of (A) a-glucosidase, (B) a-amylase and (C) PTP1B of CoTE and its
soluble fractions. Mean ± SE (n ¼ 3). Different letters (aed) in the ﬁgure are signiﬁ-
cantly different at the level of p < 0.05 according to Scheffe's test. HSF ¼ n-hexane
soluble fraction, EASF ¼ ethyl acetate soluble fraction, BSF ¼ n-butanol soluble fraction,
WSF ¼ water soluble fraction. IC50 value of HSF against a-amylase was > 1000 mg/mL.
IC50 values of acarbose against (A) a-glucosidase and (B) a-amylase were 0.004 mg/mL
and 12.5 mg/mL (C) IC50 value of ursolic acid against PTP1B was 4.6 mg/mL.
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and its four soluble fractions (Fig. 1B) showed a similar trend as that
of a-glucosidase, with BSF exhibiting the best a-amylase inhibitory
activity (IC50 ¼ 57.4 mg/mL). Taken together, these results revealed
that BSF had the best antihyperglycemic activities. The IC50 values
of PTP1B inhibitory activity (Fig. 1C) in increasing order are as fol-
lows: BSF (1.7 mg/mL)  crude (1.9 mg/mL) ¼ WSF (1.9 mg/
mL)  EASF (2.0 mg/mL) < HSF (3.2 mg/mL). Note that ursolic acid
having an IC50 value of 4.6 mg/mL reveals that it is less effective than
crude extract and its four soluble fractions. This result demon-
strated that CoTE had better PTP1B inhibitory activity than that of
the positive control and showed greater potential for improvement
of insulin or leptin resistance in type 2 diabetes.
Yilmazer-Musa et al34 reported that epi-gallocatechin gallate, a
proanthocyanidins structure unit, had the best a-glucosidase
inhibitory activity. In addition, the grape seed extract owing to their
high condensed tannin contents had excellent a-amylase inhibitoryactivity. The structure and degree of polymerization of condensed
tannin were reported to affect the inhibitory activities of glucose
and lipid metabolic enzymes.35 Similarly, BSF of CoTE had excellent
antihyperglycemic activities because of its highest proanthocyani-
din and condensed tannin contents.
In general, it was reported that proanthocyanidin and
condensed tannin exhibited strong inhibitory activities against a-
glucosidase and a-amylase.36,37 The proanthocyanidin and
condensed tannin contents of WSF (189.0 mg of CE/g and 125.5 mg
of ME/g, respectively) were higher than those of EASF (88.4 mg of
CE/g and 90.6 mgof ME/g, respectively) (Table 2). It was expected
that WSF would have better a-glucosidase and a-amylase inhibi-
tory activities than EASF; however, their a-glucosidase and a-
amylase inhibitory activities were in fact similar. On the other hand,
EASF has higher contents of ﬂavonoid glycosides (52.7 mg of RE/g)
than WSF (0.7 mg of RE/g). Lin and Chang38 reported that 9
kaempferol glycosides were obtained from CoTE, and these
kaempferol glycosides contained xylopyranosyl, arabinofuranosyl,
rhamnopyranosyl, apiofuranosyl or glucopyranosyl group. It was
reported by Pereira et al39 that kaempferitrin signiﬁcantly inhibited
the in vivo activities of maltase and sucrase. Taken together, these
results reveal that kaempferol glycosides in CoTE may contribute to
extra a-glucosidase and a-amylase inhibitory activities of EASF.
Arya et al40 reported that Centratherum anthelminticum seed
extracts in six plants in South India and Southeast Asia had excel-
lent PTP1B inhibitory activity and were the most effective in
decreasing blood glucose of diabetic rats. In addition, the total
phenolic contents of C. anthelminticum seed extracts were 665.3mg
of GAE/g. In another study, Muthusamy et al41 reported that the
condensed tannin from leaf extracts of Cichorium intybus could
inhibit PTP1B expression. Therefore, leaf extracts of C. intybus could
decrease accumulation of lipid and increase glucose uptake in 3T3-
L1 adipocytes. C. anthelminticum seed extracts had a lower PTP1B
inhibitory activity than ursolic acid, but CoTE, containing abundant
proanthocyanidin and condensed tannin, had higher PTP1B inhib-
itory activity than ursolic acid. In other words, CoTE has potential
for use as an antihyperglycemic and antihyperlipidemic agent, and
it merits further investigations using animal tests in the near future.
3.5. Antioxidant activity of soluble fractions from CoTE
Excess nutrients may cause unfolded protein response (UPR) to
accumulate reactive oxygen species (ROS) in cells. UPR and ROS
would bring about inﬂammation which led to the symptoms of
type 2 diabetes, including insulin resistance, leptin resistance and
b-cell dysfunction.42,43 To evaluate whether the soluble fractions
from CoTE can directly decrease ROS or indirectly decrease ROS by
inhibiting Fenton reaction. Results from these assays show that
extracts with excellent antioxidant abilities had the potential for
decreasing oxidative stress. Even more important, they could
reduce dysfunction of endocrine cells in type 2 diabetes.
As shown in Fig. 2A, the IC50 values of DPPH free-radical scav-
enging activity in increasing order are as follows: BSF (11.3 mg/
mL) < crude (14.5 mg/mL) < EASF (23.7 mg/mL) < WSF (27.8 mg/
mL) < HSF (>100 mg/mL), revealing that BSF possessed the highest
antioxidant activity, which might reduce the in vivo oxidative stress
in human. As shown in Fig. 2B, the IC50 values of ferrous ion-
chelating activity in increasing order are as follows: BSF (17.7 mg/
mL) < crude (22.0 mg/mL) < WSF (35.0 mg/mL) < EASF (37.6 mg/
mL) < HSF (>100 mg/mL), revealing that BSF possessed the highest
ferrous ion-chelating activity, which might reduce generation of
hydroxyl radical by Fenton reaction.
Chau et al44 reported that the 70% ethanolic extracts of
C. osmophloeum twigs had good inhibitory activity on lipid per-
oxidation, DPPH free radical and superoxide radical. The active
Fig. 2. IC50 values of (A) DPPH free-radical scavenging and (B) ferrous ion-chelating
activity of CoTE and its soluble fractions. Mean ± SE (n ¼ 3). Different letters (aed)
in the ﬁgure are signiﬁcantly different at the level of p < 0.05 according to Scheffe's
test. EASF ¼ ethyl acetate soluble fraction, BSF ¼ n-butanol soluble fraction,
WSF ¼ water soluble fraction. (A) IC50 value of quercetin was 4.0 mg/mL (B) IC50 value
of EDTA-Na2 was 9.3 mg/mL.
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results obtained in this study showed that CoTE extracted from
70% acetone had good antioxidant activities, and the active com-
pounds are proanthocyanidin and condensed tannin. Taken
together, the ﬁndings revealed obvious variations in components
of C. osmophloeum twig extracts obtained using different solvents.
Moreover, CoTE extracted from 70% acetone had better ferrous
ion-chelating activity than that of 70% ethanolic extracts. Cooksey
et al45 reported that iron chelation therapy signiﬁcant protected
b-cell function and insulin sensitivity from diabetes in leptin-
deﬁcient ob/ob mice. Escolar et al46 reported that EDTA-based
chelation regimen reduced cardiovascular events in type 2 dia-
betes patients with myocardial infarction. According to above-
mentioned studies, it indicated that CoTE extracted from 70%Table 3
Pearson's correlation for phenolic contents, antihyperglycemic and antioxidant activities
Assay TPACa CTCb TFCc Glud
TPAC 1 0.997** 0.010 0.945**







* and ** indicate signiﬁcant correlation at 5% and 1% level of conﬁdence.
a TPAC, total proanthocyanidin contents (mg of catechin equivalent/g extract).
b CTC, condensed tannin contents (mg of melacacidin equivalent/g extract).
c TFC, total ﬂavonoid contents (mg of rutin equivalent/g extract).
d Data from inhibition activity of a-glucosidase, a-amylase and PTP1B expressed as 1/
e Data from DPPH free-radical scavenging and ferrous ion-chelating capacity expresseacetone with great ferrous ion-chelating activity have potential as
a substitution for commercial iron chelators to treat type 2
diabetes.3.6. Correlation between phenolic contents, antioxidant and
antihyperglycemic activities
To determine the relationship between phenolic contents and
potential for remedying early stages of type 2 diabetes, including
antioxidant activities and antihyperglycemic activities, correlation
analysis was employed to examine different phenolic contents,
inhibitory action of hyperglycemic enzymes such as a-glucosidase,
a-amylase and PTP1B and antioxidant activities such as DPPH free-
radical scavenging activity and ferrous ion-chelating activity.
As shown in Table 3, the correlation coefﬁcient between
proanthocyanidin and condensed tannin contents was 0.997,
revealing a highly signiﬁcant correlation between these two
phenolic contents. The correlation coefﬁcients of proanthocyanidin
contents with a-glucosidase, a-amylase, and PTP1B inhibitory ac-
tivities were 0.945, 0.870, and 0.740, respectively, indicating the
higher the proanthocyanidin contents, the better the inhibitory
activities of enzymes. The correlation coefﬁcients of proanthocya-
nidin contents with DPPH free-radical scavenging and ferrous ion-
chelating activity were 0.959 and 0.974, respectively, revealing the
higher the proanthocyanidin contents, the better the antioxidant
activities. However, ﬂavonoid glycoside contents showed no cor-
relation with inhibition of enzymes or antioxidant activities. This
might be partially due to the glycosylation of ﬂavonoids which
weakens the antihyperglycemic or antioxidant activities. In brief,
these results demonstrated that both proanthocyanidin and
condensed tannin were active compounds in CoTE.
Manaharan et al47 reported that selected tropic plant extracts
displayed highly signiﬁcant correlation between total phenolic
contents and DPPH free-radical scavenging activity. Moreover, the
correlation of antioxidant activity with a-glucosidase or a-amylase
inhibitory activity was also high. In another study, Gonçalves et al48
reported that condensed tannin formed complexes with enzymes
to quench the activity of enzymes. Our results were consistent with
those of the above-mentioned studies, demonstrating that the
phenolic structure of proanthocyanidin could scavenge DPPH free
radical and condensed tannin when aggregated with enzymes into
complexes had inhibitory activities.
The present ﬁndings from in vitro assays demonstrated that
CoTE has excellent antihyperglycemic and antioxidant effects.
Nevertheless, further studies are required to elucidate the in vivo
antihyperglycemic and antioxidant activities. Moreover, the rela-
tionship between bioactivities and structure of proanthocyanidins,of CoTE and its four soluble fractions.
Amyd PTP1Bd DPPHe Chelatinge
0.870** 0.740** 0.959** 0.974**
0.860** 0.752** 0.973** 0.984**
0.042 0.300 0.257 0.177
0.843** 0.748** 0.972** 0.967**





d as 1/IC50 values.
Fig. 3. Cell viability of CoTE and its soluble fractions. Mean ± SE (n ¼ 3). Different
letters (a-c, A-C) in the ﬁgure are signiﬁcantly different at the level of p < 0.05 ac-
cording to Scheffe's test. Cell line: 3T3-L1 preadipocytes, HSF ¼ n-hexane soluble
fraction, EASF ¼ ethyl acetate soluble fraction, BSF ¼ n-butanol soluble fraction,
WSF ¼ water soluble fraction.
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polymerization, merit further investigations.3.7. Cell toxicity of soluble fractions from CoTE on 3T3-L1
preadipocyte cells
Under energy overload, adipocytes serve not only as the primary
storage site, but also secrete unsaturated or saturated fatty acid to
affect the gene expression in muscle or liver, and then regulate fat
metabolism and glucose homeostasis. Same as tissues of other
endocrine organs, adipose tissue released adipokines such as leptin,
adiponectin and resistin, which regulated insulin action and
metabolism in other tissues. For this reason, adipocytes played an
important role in energy metabolism and might contribute to
alternative novel therapies for obesity-related diseases.3
Fig. 3 shows the effects of toxicity of crude extracts and its four
soluble fractions on viability of 3T3-L1 preadipocytes. Except for
EASF, the viability of crude extracts and other soluble fractionswere
higher than 80% at 50 mg/mL. At treatment concentration of 100 mg/
mL, crude extract and other soluble fractions had no toxicity on
viability of 3T3-L1 preadipocytes while EASF decreased cell
viability to 56.1%. These results revealed that CoTE had no toxicity
on 3T3-L1 preadipocytes at 100 mg/mL. Even though EASF was toxic
to 3T3-L1 preadipocytes, crude extract comprised only 4.7% EASF.
In other words, the metabolism of adipocytes remained unaffected
by extracts at the concentration of 100 mg/mL. In addition, CoTE
may still display excellent inhibition on both glucose metabolism
enzymes and antioxidant activities, and recover the balance
metabolism of adipocytes from energy overload at the dosage of
100 mg/mL.4. Conclusions
To the best of our knowledge, this is the ﬁrst report demon-
strating that indigenous cinnamon (C. osmophloeum;土肉桂 tǔ rou
guì) twig extracts has antihyperglycemic effects as evidenced by
both a-glucosidase and a-amylase inhibitory activity assays.
Furthermore, it is of note that CoTE has PTP1B inhibitory activity to
improve insulin or leptin resistance. In addition, CoTE displays
antioxidant activities, and has the potential for decreasing oxidative
stress in type 2 diabetes. The above-mentioned activities were
attributed to the abundant proanthocyanidins and condensed
tannins in CoTE. CoTE has good potential as a renewable source for
natural health products due to its antihyperglycemic activity,
antioxidant activity and non-toxic properties.Conﬂict of interest
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